[ad_1] but should consult their doctor, warns the National Institute of Patient Control . The State Institute for Drug Control, 4/7/2018, took all necessary measures to protect the patient. He ordered the …
Read More »Despite the withdrawal of the drug against hypertension with the active ingredient valsartan market, patients should not get rid of the drug immediately. The European Medicines Agency ordered a review of drugs containing the active substance valsartan after the detection of an NDMA impurity in the active substance
